Chronic Total Occlusion Percutaneous Coronary Intervention: Present and Future.

Journal: Circulation. Cardiovascular interventions
Published Date:

Abstract

Chronic total occlusion percutaneous coronary intervention has evolved into a subspecialty of interventional cardiology. Using a variety of antegrade and retrograde techniques, experienced operators currently achieve success rates of 85% to 90%, with an incidence of major periprocedural complications of ≈2% to 3%. Several developments in equipment (new microcatheters and guidewires, novel reentry devices), imaging (computed tomography angiography guidance, intravascular imaging for reentry), techniques (intraocclusion contrast injection, advanced subintimal tracking and reentry), and artificial intelligence (automated computed tomography image analysis and prediction of the likelihood of crossing success with various techniques) could further improve outcomes. Global collaboration and rapid dissemination of new developments accelerate the pace of progress. While innovation is exciting and necessary, adhering to the basic principles of chronic total occlusion percutaneous coronary intervention (such as continual assessment of risks and benefits, meticulous angiographic review, and use of dual injection) remains critical for achieving optimal patient outcomes.

Authors

  • Emmanouil S Brilakis
    Center for Advanced Coronary Interventions, Minneapolis Heart Institute, Minneapolis, Minnesota, USA.
  • Yader Sandoval
    Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Lorenzo Azzalini
    Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Gregor Leibundgut
    Department of Cardiology, University Hospital Basel, Switzerland (G.L.).
  • Roberto Garbo
    Maria Pia Hospital, GVM Care and Research, Turin, Italy (R.G.).
  • Allison B Hall
    Memorial University of Newfoundland/NL Health Services, St John's, Canada (A.B.H.).
  • Rhian E Davies
    Wellspan Health, York, PA (R.E.D.).
  • Kambis Mashayekhi
    Division of Cardiology and Angiology II, University Heart Center Freiburg - Bad Krozingen, and Division of Internal Medicine and Cardiology, Heart Center Lahr, Germany (K.M.).
  • Masahisa Yamane
    Saitama-Sekishinkai Hospital, Japan (M.Y.).
  • Alexandre Avran
    Valenciennes Hospital, France (A.A.).
  • Jaikirshan J Khatri
    Cleveland Clinic, Cleveland, Ohio, USA.
  • Khaldoon Alaswad
    Henry Ford Cardiovascular Division, Detroit, Michigan, USA.
  • Farouc A Jaffer
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Stephane Rinfret
    Emory University Hospital Midtown, Atlanta, Georgia, USA.